PHARMACEUTICAL COMPOSITION AND METHOD FOR IDENTIFYING A CANCEROUS AND/OR AN INFLAMMATORY DISEASE IN A PATIENT

摘要

The invention relates to a method for identifying prostate cancer in a patient that includes at least the step of examining if at least a protein cluster (CMP) or a group of CMPs containing at least CD26 and CD29 can be identified on the cell surfaces of cells from a part of the body of the patient, wherein the part of the body is prostate tissue and is suspected to be affected by prostate cancer.